Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 562
- Value
- $282.0K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 562 | $282.0K | <0.1% | −2−0.4% | Reduced | Holders |
| Q1 2026 | 564 | $277.4K | <0.1% | −9−1.6% | Reduced | Holders |
| Q4 2025 | 573 | $332.3K | <0.1% | −5−0.9% | Reduced | Holders |
| Q3 2025 | 578 | $280.5K | <0.1% | +2+0.3% | Added | Holders |
| Q2 2025 | 576 | $233.7K | <0.1% | +3+0.5% | Added | Holders |
| Q1 2025 | 573 | $285.3K | <0.1% | +573 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −1,711−100.0% | Sold out | Holders |
| Q2 2023 | 1,711 | $892.9K | 0.1% | +44+2.6% | Added | Holders |
| Q1 2023 | 1,667 | $961.0K | 0.1% | +95+6.0% | Added | Holders |
| Q4 2022 | 1,572 | $865.9K | 0.1% | +77+5.2% | Added | Holders |
| Q3 2022 | 1,495 | $758.0K | 0.1% | +81+5.7% | Added | Holders |
| Q2 2022 | 1,414 | $768.0K | 0.1% | +61+4.5% | Added | Holders |
| Q1 2022 | 1,353 | $799.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,353 | $903.0K | 0.1% | +85+6.7% | Added | Holders |
| Q3 2021 | 1,268 | $725.0K | 0.1% | −72−5.4% | Reduced | Holders |
| Q2 2021 | 1,340 | $676.0K | 0.1% | +13+1.0% | Added | Holders |
| Q1 2021 | 1,327 | $606.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.